Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC) ...
MedPage Today on MSN13dOpinion
We're Getting the Medicaid Message Wrong — And It's Costing UsMedicaid serves lower-income adults, children, pregnant women, and people with disabilities, as well as dually-enrolled ...
Rikers Island correction captains and officers revived a man who had overdosed on drugs, and a detainee with a long record of ...
“The KickStart Grant Awards help de-risk these technologies by establishing a collaboration agreement between the startup ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
The company introduced technologies like Next-Generation Sequencing and Sanger Sequencing nearly a decade ago.
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback